![Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13052-021-00962-4/MediaObjects/13052_2021_962_Fig2_HTML.png)
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text
![Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13063-022-07051-9/MediaObjects/13063_2022_7051_Fig1_HTML.png)
Multi-centre, randomised, open-label, blinded endpoint assessed, trial of corticosteroids plus intravenous immunoglobulin (IVIG) and aspirin, versus IVIG and aspirin for prevention of coronary artery aneurysms (CAA) in Kawasaki disease (KD): the KD
![Frontiers | Aspirin Dose and Treatment Outcomes in Kawasaki Disease: A Historical Control Study in Japan Frontiers | Aspirin Dose and Treatment Outcomes in Kawasaki Disease: A Historical Control Study in Japan](https://www.frontiersin.org/files/Articles/522921/fped-08-00249-HTML-r1/image_m/fped-08-00249-t001.jpg)
Frontiers | Aspirin Dose and Treatment Outcomes in Kawasaki Disease: A Historical Control Study in Japan
![Treat acute Kawasaki disease with aspirin plus intravenous immunoglobulin to improve coronary outcomes | SpringerLink Treat acute Kawasaki disease with aspirin plus intravenous immunoglobulin to improve coronary outcomes | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2FBF03262128/MediaObjects/40267_2012_2128_FigU1.jpg)
Treat acute Kawasaki disease with aspirin plus intravenous immunoglobulin to improve coronary outcomes | SpringerLink
![Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13052-021-00962-4/MediaObjects/13052_2021_962_Fig1_HTML.png)
Revised recommendations of the Italian Society of Pediatrics about the general management of Kawasaki disease | Italian Journal of Pediatrics | Full Text
![Dr Joshua Walinjom on X: "Treatment for Kawasaki Disease 1. intravenous gamma globulin (IVIG) 2. high-dose Aspirin https://t.co/k28tTOpNYz" / X Dr Joshua Walinjom on X: "Treatment for Kawasaki Disease 1. intravenous gamma globulin (IVIG) 2. high-dose Aspirin https://t.co/k28tTOpNYz" / X](https://pbs.twimg.com/media/FbWZfgfXwAADg1B.jpg)
Dr Joshua Walinjom on X: "Treatment for Kawasaki Disease 1. intravenous gamma globulin (IVIG) 2. high-dose Aspirin https://t.co/k28tTOpNYz" / X
![Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial - The Lancet Child & Adolescent Health Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial - The Lancet Child & Adolescent Health](https://www.thelancet.com/cms/asset/4dd43524-dcf7-466a-a39e-5413f3d8ea78/gr1.gif)